Every patient in a standardized trial of sunscreens quickly reached systemic concentrations of the active ingredients that exceeded the level the FDA views as a trigger for systemic safety testing. Medscape Medical News …read more
Physicians prescribing SGLT2 inhibitors, a newer class of diabetes drugs, are advised to “have a high index of suspicion” about the potentially fatal complication. Medscape Medical News …read more
An international Medscape survey finds that just 20% of physicians say artificial intelligence (AI) has changed the way they practice, but 70% say it will eventually make their decisions more accurate. Medscape Medical News …read more
These are the first FDA-approved treatments for transthyretin-mediated amyloidosis cardiomyopathy, a rare and often fatal disease caused by deposition of amyloid fibrils in the myocardium. FDA Approvals …read more